In this episode, Keith R. McCrae, MD; Nichola Cooper, MD; and Rachael Grace, MD, MMSc,provide expert insights on immune thrombocytopenia management, along with addressing frequently asked questions from a live CCO symposium. Topics include:

• New and emerging therapeutic options
• Special patient populations, including children
• The management of immune thrombocytopenia
• COVID-19 vaccinations and immune thrombocytopenia

Presenters:

Keith R. McCrae, MD
Professor of Molecular Medicine
Department of Hematology and Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio, USA

Nichola Cooper, MD
Honorary Consultant Hematologist
Hammersmith Hospital
Imperial College
London, United Kingdom

Rachael Grace, MD, MMSc
Associate Professor of Pediatrics
Harvard Medical School
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Boston, Massachusetts, USA

Content based on an online CME program supported by an educational grant from Amgen; Dova Pharmaceuticals, Inc.; and Sanofi Genzyme.

Advances in Immune Thrombocytopenia:
https://bit.ly/3gzykzy

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.